F13.250
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.250 describes a specific mental health condition characterized by dependence on sedatives, hypnotics, or anxiolytics, combined with a psychotic disorder caused by these substances. Individuals with this condition experience a complex interplay of addiction and psychosis, which can significantly impact their daily functioning and mental well-being. Recognizing this condition is essential for appropriate treatment and management.
Causes & Symptoms
Clinical Causes: Repeated and prolonged use of sedative, hypnotic, or anxiolytic medications, often prescribed for sleep, anxiety, or other mental health issues. Development of physical and psychological dependence on these drugs, leading to cravings and compulsive drug-seeking behavior. Individual vulnerabilities such as genetic predispositions, underlying mental health conditions, or environmental stressors may increase the risk of developing dependence. Misuse or recreational use of sedatives or anxiolytics outside prescribed guidelines can contribute to dependence. Extended use of high doses or abrupt discontinuation may trigger withdrawal symptoms and exacerbate psychiatric issues.
Key Symptoms: Delusions related to paranoia, grandeur, or other false beliefs that are not grounded in reality. Hallucinations, including auditory or visual disturbances that the individual perceives as real. Dependence symptoms such as a strong desire or craving for the drug, withdrawal signs upon cessation, and difficulty controlling use. Behavioral signs like seeking out the drugs compulsively, neglecting responsibilities, or social withdrawal. Cognitive impairments, including confusion, disorganized thinking, or difficulty concentrating. Mood disturbances, which may include agitation, anxiety, or depression. Physical signs of dependence, such as tremors, sweating, or other withdrawal symptoms if drug use is reduced abruptly.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical assessment that includes a detailed history of medication use, evaluation of dependence symptoms, and identification of psychotic features. Healthcare professionals may use standardized tools and criteria to confirm the presence of sedative, hypnotic, or anxiolytic dependence alongside psychotic disorder with delusions. Medical tests may be employed to rule out other causes of psychosis.
Treatment Protocols: Gradual tapering of the sedative, hypnotic, or anxiolytic medication to reduce withdrawal symptoms and dependence. Psychopharmacological interventions to manage psychotic symptoms, which may include antipsychotic medications. Psychotherapy approaches such as cognitive-behavioral therapy (CBT) to address underlying issues, modify maladaptive thoughts, and develop coping skills. Support groups and social support to assist with recovery and prevent relapse. Monitoring and managing withdrawal symptoms carefully under medical supervision. Addressing any underlying mental health conditions or co-occurring disorders.
Clinical Advice & FAQs
Billing Guidance
Is F13.250 a billable ICD-10 code?
Yes, F13.250 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.250?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
